| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOGEN INC | 50,000 | 15,766,000 | 4.68% | ||
| 2 | COVIDIEN PLC | 171,000 | 15,421,000 | 4.58% | ||
| 3 | GILEAD SCIENCES INC | 180,000 | 14,924,000 | 4.43% | ||
| 4 | ALEXION PHARMACEUTIC | 93,000 | 14,531,000 | 4.31% | ||
| 5 | CELGENE CORP | 156,781 | 13,464,000 | 4.00% | ||
| 6 | VERTEX PHARMACEUT | 101,600 | 9,619,000 | 2.85% | ||
| 7 | BIOMARIN | 150,000 | 9,332,000 | 2.77% | ||
| 8 | ALKERMES PLC SHS | 168,000 | 8,455,000 | 2.51% | ||
| 9 | INCYTE | 133,000 | 7,507,000 | 2.23% | ||
| 10 | CARDINAL HEALTH INC | 99,000 | 6,787,000 | 2.01% | ||
| 11 | Allergan plc | 40,000 | 6,769,000 | 2.01% | ||
| 12 | REGENERON PHARMACEUTICALS | 22,500 | 6,356,000 | 1.89% | ||
| 13 | ALLERGAN PLC | 25,000 | 5,576,000 | 1.65% | ||
| 14 | SALIX PHARMACEUTICALS INC | 43,493 | 5,365,000 | 1.59% | ||
| 15 | BOSTON SCIENTIFIC CORP | 415,000 | 5,300,000 | 1.57% | ||
| 16 | ACADIA PHARMACEUTICALS INC COM | 230,000 | 5,196,000 | 1.54% | ||
| 17 | CIGNA CORPORATION | 55,000 | 5,058,000 | 1.50% | ||
| 18 | PHARMACYCLICS INC | 55,000 | 4,934,000 | 1.46% | ||
| 19 | COMMUNITY HEALTH SYS INC NEW COM | 102,000 | 4,628,000 | 1.37% | ||
| 20 | LIVANOVA PLC | 74,000 | 4,622,000 | 1.37% | ||
| 21 | MERCK & CO INC | 78,000 | 4,512,000 | 1.34% | ||
| 22 | BRISTOL MYERS SQUIBB CO | 85,000 | 4,123,000 | 1.22% | ||
| 23 | MEDIVATION INC | 52,000 | 4,008,000 | 1.19% | ||
| 24 | MCKESSON CORP | 21,500 | 4,004,000 | 1.19% | ||
| 25 | INSULET CORPORATION | 100,000 | 3,967,000 | 1.18% | ||
| 26 | DEXCOM | 100,000 | 3,966,000 | 1.18% | ||
| 27 | THERMO FISHER SCIENTIFIC INC | 33,000 | 3,894,000 | 1.16% | ||
| 28 | CVS HEALTH CORP | 50,000 | 3,769,000 | 1.12% | ||
| 29 | CLOVIS ONCOLOGY INC | 90,000 | 3,727,000 | 1.11% | ||
| 30 | KERYX BIOPHARMACEUTICALS INCORPORATED | 240,000 | 3,691,000 | 1.10% | ||
| 31 | HCA HOLDINGS INC | 60,000 | 3,383,000 | 1.00% | ||
| 32 | NEKTAR THERAPEUTICS COM | 260,000 | 3,333,000 | 0.99% | ||
| 33 | CELLDEX THERAPEUTICS INC NEW | 199,000 | 3,248,000 | 0.96% | ||
| 34 | ENDOLOGIX INC | 205,000 | 3,118,000 | 0.93% | ||
| 35 | MYRIAD GENETICS INC | 80,000 | 3,114,000 | 0.92% | ||
| 36 | CATAMARAN CORP COM | 70,000 | 3,091,000 | 0.92% | ||
| 37 | Anthem, Inc. | 28,000 | 3,013,000 | 0.89% | ||
| 38 | EDWARDS LIFESCIENCES CORP | 35,000 | 3,004,000 | 0.89% | ||
| 39 | PAREXEL INTL CORP | 55,000 | 2,906,000 | 0.86% | ||
| 40 | UNIVERSAL HLTH SVCS INC | 30,000 | 2,873,000 | 0.85% | ||
| 41 | VARIAN MED SYS I | 34,000 | 2,827,000 | 0.84% | ||
| 42 | REVANCE THERAPEUTICS INC COM | 82,000 | 2,788,000 | 0.83% | ||
| 43 | ST JUDE | 40,000 | 2,770,000 | 0.82% | ||
| 44 | LILLY ELI & CO | 44,500 | 2,767,000 | 0.82% | ||
| 45 | NUVASIVE INC COM | 76,000 | 2,703,000 | 0.80% | ||
| 46 | ABIOMED INC | 107,000 | 2,690,000 | 0.80% | ||
| 47 | CENTENE CORP DEL | 35,000 | 2,646,000 | 0.79% | ||
| 48 | UNITEDHEALTH GROUP INC | 32,000 | 2,616,000 | 0.78% | ||
| 49 | LIGAND PHARMACEUTICALS INC | 42,000 | 2,616,000 | 0.78% | ||
| 50 | ACHILLION PHARMACEUTICALS INC COM | 330,000 | 2,498,000 | 0.74% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-14-002277, filed 2014.07.31).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
